2m 2m 2m 2m 2m 2m 2m
Alpha Tau Med (DRTS)
NASDAQ
$12.35+$0.17 (+1.35%)
Price as of Jul 13, 2026 7:58 PM EDT- $423.8MMarket Cap
- 277.09%1-Year Change
- BiotechnologyIndustry
Alpha Tau Med (DRTS)
$12.35+$0.17 (+1.35%)
DRTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.18 | ||
Change | -$0.53 (-4.17%) | ||
Open | $12.38 | ||
High | $12.55 | ||
Low | $11.95 | ||
Previous Close | $12.71 | ||
Volume | 706,406 | ||
30-Day Average Volume | 834,201 | ||
1-Week Change | -10.28% | ||
1-Month Change | 23.65% | ||
1-Year Change | 277.09% | ||
3-Year Change | 194.20% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.3M | ||
Total Assets | $105.7M | ||
Market Cap | $423.8M | ||
Enterprise Value | $417.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue